瑞安吉口服液治疗轮状病毒肠炎心肌损害的疗效观察

目的观察瑞安吉口服液治疗轮状病毒肠炎心肌损害的疗效。方法将47例轮状病毒肠炎并发心肌损害患儿随机分为治疗组26例和对照组21例，两组均给予低（去）乳糖饮食、补液、补充电解质、维持酸碱平衡和黏膜保护剂、微生态制剂及消旋卡多曲颗粒等常规治疗。治疗组在此基础上加用瑞安吉口服液，治疗7d。治疗后复查两组CK—MB质量浓度及心电图。结果治疗后两组CK—MB均有下降，但对照组明显高于治疗组，差异有统计学意义（P〈0．05）；治疗组有效率明显高于对照组，差异有统计学意义（P〈0．05）。结论瑞安吉口服液治疗婴幼儿轮状病毒肠炎合并心肌损害疗效好，值得推广。

Observation on Efficacy of Fructose Sodium Diphosphate Oral Solution in Treating Infant Rotavirus Enteritis Combined with Myocardial Damage

Objective To investigate the efficacy of Fructose Sodium Diphosphate Oral Solution in treating infant rotavirus enteritis combined with myocardial damage. Methods Forty seven cases of infant rotavirus enteritis combined with myocardial damage were randomly divided into treatment group of 26 cases and control group of 21 cases. Two groups were both treated with low-lactose diets, fluid and electrolyte supplement, mucosal protective agent, probiotics and racecadotril particles and other conventional treatment. The treatment group was additionally treated with Fructose Sodium Diphosphate Oral Solution for 7 days. CK-MB mass and ECG of both groups were reexamined. Results After treatment, the levels of CK-MB mass were decreased in both two groups, but CK-MB level of the control group was significantly higher than the treatment group, the difference was statistically significant （P 〈 0.05）; The efficiency of the treatment group was obviously higher than that of the control group and the difference was statistically significant （P 〈 0.05）. Conclusion The efficacy of Fructose Sodium Diphosphate Oral Solution in treatment of infant rotavirus enteritis combined with myocardial damage is good enough to be widely applied.